Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Mettler-Toledo International's EV-to-EBIT or its related term are showing as below:
FRA:MTO'
s EV-to-EBIT Range Over the Past 10 Years
Min: 20.52 Med: 27.74 Max: 41.96
Current: 25.76
During the past 13 years, the highest EV-to-EBIT of Mettler-Toledo International was 41.96. The lowest was 20.52. And the median was 27.74.
FRA:MTO's EV-to-EBIT is ranked worse than 57.69% of 104
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.565
vs FRA:MTO: 25.76
Mettler-Toledo International (FRA:MTO) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Mettler-Toledo International's Enterprise Value for the quarter that ended in Mar. 2026 was €23,821 Mil.
Mettler-Toledo International's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €967 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International EV-to-EBIT Related Terms
Mettler-Toledo International EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Mettler-Toledo International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International EV-to-EBIT vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's EV-to-EBIT falls into.
Mettler-Toledo International's current Enterprise Value is €25,480 Mil.
Mettler-Toledo International's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €967 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International (FRA:MTO) has a EV-to-EBIT of 26.36 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mettler-Toledo International and its competitors. This is near median its historical median of 27.74. Over the past decade, Mettler-Toledo International's EV-to-EBIT has ranged from 20.52 to 41.96. According to the industry distribution chart, Mettler-Toledo International ranks #60 out of 104 companies in the Medical Diagnostics & Research industry, placing it in the top 57.7%.
Is Mettler-Toledo International's EV-to-EBIT too high?
Mettler-Toledo International's current EV-to-EBIT of 26.36 is near median its 10-year median of 27.74. Over the past 10 years, this metric has ranged from a low of 20.52 to a high of 41.96. The Medical Diagnostics & Research industry median EV-to-EBIT is 22.57. Mettler-Toledo International's value of 26.36 is 16.8% above this industry median. Based on the distribution chart, Mettler-Toledo International ranks #60 out of 104 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Mettler-Toledo International has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's EV-to-EBIT compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #60 out of 104 companies for EV-to-EBIT. This places Mettler-Toledo International in the lower half of its industry. The industry median EV-to-EBIT is 22.57. Mettler-Toledo International's value of 26.36 is 16.8% above this benchmark. Historically, Mettler-Toledo International's own EV-to-EBIT has ranged from 20.52 to 41.96 over the past decade. While the company's 10-year median is 27.74 vs. the industry median of 22.57, Mettler-Toledo International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Diagnostics & Research company?
The median EV-to-EBIT among Medical Diagnostics & Research companies is 22.57, based on 104 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mettler-Toledo International's current EV-to-EBIT of 26.36 is 16.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mettler-Toledo International and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-EBIT is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current EV-to-EBIT is 26.36, which is near median its own 10-year median of 27.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Mettler-Toledo International (FRA:MTO) has a current EV-to-EBIT of 26.36. The stock's GF Value™ is €1,263.21, compared to a current price of €1,166.00 — trading 7.7% below its estimated fair value. The current EV-to-EBIT is 26.36, which is near median its 10-year median of 27.74 and 16.8% above the Medical Diagnostics & Research industry median of 22.57. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current EV-to-EBIT is 26.36 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,166.00 is trading 7.7% below its estimated GF Value™ of €1,263.21.
Key valuation signals for FRA:MTO:
EV-to-EBIT: 26.36 (near median its 10-year median of 27.74)
GF Value™: €1,263.21 vs. price of €1,166.00 (7.7% below fair value)
Industry Position: 16.8% above the Medical Diagnostics & Research median (#60 of 104)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for FRA:MTO
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
